The sequencing of the human genome together with the development and implementation of new high throughput technologies (so called “omics”) are enhancing our knowledge on human health and disease and have already, and will continue, to provide a sound foundation for personalised medicine. The workshop “Omics in personalised medicine” that was held at the European Commission in Brussels on 29th and 30th of April, brought together experts from different fields: omics, epidemiology, pharmacology, experimental medicine and bioinformatics representing academia, industry, including SMEs, and regulatory and funding agencies. The aim of the workshop was to explore the.
